<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01566955</url>
  </required_header>
  <id_info>
    <org_study_id>UMM-Mannheim</org_study_id>
    <nct_id>NCT01566955</nct_id>
  </id_info>
  <brief_title>Feasability Study of Removing the Ovaries and Fallopian Tubes</brief_title>
  <acronym>TG-Adnex</acronym>
  <official_title>Feasability of Transgastric Adnexectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heidelberg University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main reason for this trial is to show the feasibility of removing the ovarien and
      fallopian tubes through the gaster (transgastric adnexectomy). The background for it is to
      look for more indications of scarless surgery and we will show that the transgastric
      adnexectomy can be performed in an easy way. It is necessary that there is an indication for
      removing the ovaries and fallopian tubes and if the patient agree we will do it instead of
      through the belly through the gaster and maybe with an additional inzision in the vagina. All
      patients with indication for adnexectomy are potential candidates.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We will show the feasibility for transgastric adnexectomy in 10 patients. Patients for
      participating in the study suffer of benign adnexal deseases and there is an indication for
      removing them for diagnostic, prophylactic or therapeutic reasons. A flexible gastric scope
      is put transgastric into the abdomen, developing an pneumoperitoneum and removing the adnexes
      with a monopolar knife. The adnexes then are put out of the abdomen either transvaginally
      after colpotomy or even transgastric. We already performed an appendectomy in 24 patients and
      were able to show the feasibility in acute infectios situations.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants with conversion to laparoscopy or laparotomy</measure>
    <time_frame>12 months</time_frame>
    <description>With the trial we want to demonstrate that the transgastric adnexectomy is possible. We will document the number of patients in which we have to change the transgastric to a laparoscopic or laparotomic operation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative well being</measure>
    <time_frame>6 weeks and 6 months</time_frame>
    <description>Postoperative well being after 6 weeks and after 6 months (standardized questionaire of our hospital)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Ovarian Diseases</condition>
  <arm_group>
    <arm_group_label>transgastric adnexectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients are operated transgastric</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>transgastric adnexectomy</intervention_name>
    <description>adnexectomy transgastrically with transvaginal support</description>
    <arm_group_label>transgastric adnexectomy</arm_group_label>
    <other_name>NOTES</other_name>
    <other_name>Pure NOTES</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Indication for adnexectomy, agreement to take part in the study

        Exclusion Criteria:

          -  No agreement in the trial; patients younger than 18 years of age
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc Suetterlin, MD; PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Heidelberg, University Medical Center Mannheim Department of Obstetric and Gynaecology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Medical Center Mannheim</name>
      <address>
        <city>Mannheim</city>
        <state>Baden-WÃ¼rttemberg</state>
        <zip>68135</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Hornemann A, Suetterlin M, Trunk MJ, Gerhardt A, Kaehler G. Pure natural orifice transluminal endoscopic surgery (NOTES) involving peroral endoscopic salpingo-oophorectomy (POESY). Int J Gynaecol Obstet. 2014 Apr;125(1):86-8. doi: 10.1016/j.ijgo.2013.08.024. Epub 2014 Jan 2.</citation>
    <PMID>24434232</PMID>
  </reference>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2012</study_first_submitted>
  <study_first_submitted_qc>March 27, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2012</study_first_posted>
  <last_update_submitted>May 26, 2015</last_update_submitted>
  <last_update_submitted_qc>May 26, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heidelberg University</investigator_affiliation>
    <investigator_full_name>Dr. med. Amadeus Hornemann, MPH</investigator_full_name>
    <investigator_title>Dr. Amadeus Hornemann, MPH, PhD</investigator_title>
  </responsible_party>
  <keyword>transgastric</keyword>
  <keyword>NOTES</keyword>
  <keyword>Gastrotomy</keyword>
  <keyword>BRCA 1/2</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ovarian Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

